DISPATCHES FROM INTERPHEX

To QbD or not to QbD? For biologics it's a must says Cook Pharmica expert

By Dan Stanton

- Last updated on GMT

Related tags: Protein

The thorny issue of applying QbD to biopharmaceutical manufacture is a topic of hot debate at Interphex 2014 according to CMO Cook Pharmica.

Recently, progress has been made in the application of quality by design (QbD) to biopharmaceuticals, notably as a result of the US Food and Drug Administration’s (FDA) publication​ of process validation guidelines that integrated ICH principals.

But for biopharmaceutical manufacturers the additional complexity of using QbD can be an issue according to Kumar​ Dhanasekharan, director of process development for biologics at Cook Pharmica.

It is a bit more complicated [to apply QbD to biopharmaceuticals] than it is to small molecules simply because the analytical methods we use for biologics are not able to characterise the molecule to the same extent.”

He explained that while for small molecules analytical methods can determine the structure and its entire makeup from an efficacy and safety perspective, this is just not possible for biologics.

For a biologics the QbD depends upon the analytical methods we have. Obviously we can look at the amino acid sequence, the secondary and tertiary structure of the protein but you really never fully characterise the molecule.”

Related news

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Manufacturing of hiPSC-Derived Cardiomyocytes

Manufacturing of hiPSC-Derived Cardiomyocytes

Eppendorf for Bioprocess – Solutions that grow with you | 29-Oct-2020 | Application Note

Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent...

Related suppliers

Follow us

Products

View more

Webinars